BNP Paribas Financial Markets’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Hold
0
-$10 4514
2019
Q3
Hold
0
4487
2019
Q2
Hold
0
4508
2019
Q1
Hold
0
4439
2018
Q4
Hold
0
4458
2018
Q3
Hold
0
4439
2018
Q2
Hold
0
4409
2018
Q1
Hold
0
4210
2017
Q4
Hold
0
-$7 4323
2017
Q3
Hold
0
4223
2017
Q2
Hold
0
4236
2017
Q1
Hold
0
-$1.07K 4289
2016
Q4
Sell
-2
Closed -$9.69K 4014
2016
Q3
$8.4K Buy
2
+1
+100% +$6.42K ﹤0.01% 3256
2016
Q2
$6.54K Buy
+1
New +$10.1K ﹤0.01% 3130
2015
Q2
Hold
0
-$3.05K 3646
2015
Q1
Hold
0
3379
2014
Q4
Sell
-1
Closed -$8.91K 3358
2014
Q3
$8.91K Buy
+1
New +$9.65K ﹤0.01% 3646

Other funds holding BPTH

BNP Paribas Financial Markets's BPTH Position: Q4 2019 in Review

BNP Paribas Financial Markets held its Bio-Path Holdings Inc (BPTH) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

BNP Paribas Financial Markets first reported a position in BPTH in Q3 2014 and has held it in 3 quarters since. The position peaked at $8.91K in Q3 2014. 15 funds tracked by Wall St. Rank hold BPTH as of Q4 2019.

  • BNP Paribas Financial Markets held 0 shares of Bio-Path Holdings Inc worth $0 as of Q4 2019.
  • BNP Paribas Financial Markets left its Bio-Path Holdings Inc share count unchanged in Q4 2019.
  • Bio-Path Holdings Inc made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q4 2019, its #4514 holding.
  • BNP Paribas Financial Markets first reported a position in Bio-Path Holdings Inc in Q3 2014 and has held it in 3 quarters since.
  • BNP Paribas Financial Markets's Bio-Path Holdings Inc position peaked at $8.91K in Q3 2014.
  • 15 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2019.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.